Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
about
Advances in anticancer immunotoxin therapyRituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual MeetingAntibody Therapies in Cancer.Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review.Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin's lymphomaTositumomab and iodine I 131 tositumomab (Bexaar).Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab.Transformation of follicular lymphomaTreatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.A review of tositumomab and I(131) tositumomab radioimmunotherapy for the treatment of follicular lymphoma.Review of clinical radioimmunotherapy.Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaCurrent results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma.Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantationIodine 131 tositumomab in the treatment of non-Hodgkin's lymphoma.Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphomaI-Tositumomab in lymphoma.The role of monoclonal antibodies in the treatment of lymphomas.Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells.SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.Outcome of progressive disease after autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey.Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine(131)-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma.Radioimmunotherapy of B-Cell Non-Hodgkin's Lymphoma.
P2860
Q28085551-80D19C0B-DEA6-4F69-91F9-B8CB95234BF6Q28390181-669EF6DA-E5B8-409E-A296-22DBB43D9FA7Q31104000-D9D92338-F658-40FD-BC22-836E2BB5A42BQ33374978-48FE14CF-2B3B-47E2-BCCA-5743E277D2CFQ33380518-8979F46F-C6F5-47AB-9873-303C990C48D9Q33915986-0FED402A-C0CD-494D-868B-0C74F593A9E4Q34173204-98DE0FE8-255F-4590-9372-E418FB0A0D8BQ34631795-369E527C-9D2D-4C05-B2FC-AC00E352E6C6Q35038729-2C9DF4CA-1E6A-4F14-AB3A-3B4B86E6340CQ35166811-DA807C76-42C2-43CE-99F9-0A1F72DECF1BQ36150468-821EAFDE-903D-4F47-BC77-928899C4F3DAQ36407480-D0D41431-084F-4DAA-B0C4-EBAC1255FBFAQ36426877-113F4760-C66E-4DE5-B43F-B333C6B94789Q36614459-AFBF6DBD-98F4-4F19-A4BE-2C2F73AE6D13Q36684500-0845DF7B-9FA2-484C-A709-13FF99B18654Q36837765-8D4834C6-FC3C-4CD6-A7E2-EB5436646DE6Q36839758-6E38D669-1FC4-44AA-9664-6473D974CC08Q37004739-E55AF94D-A66E-4DC6-9278-452C26FC2496Q37132380-1CD856F0-1E84-4073-A31D-FD01C8AFB1C4Q37290469-56609492-68FD-4445-8722-6B8973EF597EQ37401659-6EF7F5A9-753F-455B-AAAE-98BDD64167E7Q38069595-D80AE0AE-3886-488D-A57E-B897CC03CD7CQ38891949-BA9A668E-49C6-49E2-82B3-393E0A35D9F2Q40036380-2A575EAA-D437-4260-B207-087190FD5FC4Q44908024-CC0B2408-E234-45F8-B77F-FD8DBC195A55Q46653982-05F052A2-665E-4C77-821A-0B216A197EC5Q48085778-DEF71F8A-1408-4282-AFFE-57B8174E0C21Q55689230-CF29F7E4-BBE8-4312-88F3-2EC6093727F8
P2860
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@ast
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@en
type
label
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@ast
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@en
prefLabel
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@ast
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
P356
P1476
Tositumomab and iodine I 131 t ...... B-cell non-Hodgkin's lymphoma
@en
P2093
A J Davies
A J Norton
A Z S Rohatiner
B M Carrington
D P Deakin
I N Micallef
J A Lawrance
P304
P356
10.1200/JCO.2004.06.055
P407
P50
P577
2004-04-01T00:00:00Z